FDA Inspection 1195884 — Annette Okai, M.D.
The FDA completed an inspection of Annette Okai, M.D. on December 16, 2022 in Plano, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 16, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plano, TX (United States)
Additional Details
Clinical Investigator (CI)